A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man - PubMed (original) (raw)
A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man
S T Jalkanen et al. Eur J Immunol. 1986 Oct.
Abstract
We describe a 90-kDa lymphocyte surface glycoprotein, recognized by the monoclonal antibody Hermes-1, that is involved in endothelial cell recognition and lymphocyte trafficking in man. This molecule is selectively expressed on normal or transformed lymphoid cells that are able to recognize and bind to high endothelial venules (HEV, specialized vessels that mediate lymphocyte exit from the blood into lymphoid organs); appears to be linked to HEV recognition function since, in fluorescence-activated cell sorting of variants of a cloned cell line, HEV binding ability co-selects with the Hermes-1 antigen; bears the predominant cell surface epitopes recognized by heterologous anti-human lymphocyte antibodies able to interfere with lymphocyte binding to HEV; and is structurally similar to a previously described mouse lymphocyte surface receptor for HEV. These findings demonstrate that the molecule defined by Hermes-1 either functions as a specific lymphocyte surface receptor for HEV, or is both precisely coregulated and physically and/or functionally associated with such receptors. The expression of this putative receptor for HEV on normal human lymphocyte populations parallels, and thus presumably helps determine, their migratory status in vivo. Hermes-1 should be a powerful tool for analyzing the role of endothelial cell recognition in the traffic of normal and neoplastic human lymphocytes.
Similar articles
- Human lamina propria lymphocytes bear homing receptors and bind selectively to mucosal lymphoid high endothelium.
Jalkanen S, Nash GS, De los Toyos J, MacDermott RP, Butcher EC. Jalkanen S, et al. Eur J Immunol. 1989 Jan;19(1):63-8. doi: 10.1002/eji.1830190111. Eur J Immunol. 1989. PMID: 2465905 - Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man.
Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher EC. Jalkanen S, et al. J Immunol. 1988 Sep 1;141(5):1615-23. J Immunol. 1988. PMID: 3137259 - Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors.
Picker LJ, De los Toyos J, Telen MJ, Haynes BF, Butcher EC. Picker LJ, et al. J Immunol. 1989 Mar 15;142(6):2046-51. J Immunol. 1989. PMID: 2646376 - Specific lymphocyte-endothelial cell interactions regulate migration into lymph nodes, Peyer's patches, and skin.
Chin YH, Falanga V, Streilein JW, Sackstein R. Chin YH, et al. Reg Immunol. 1988 Jul-Aug;1(1):78-83. Reg Immunol. 1988. PMID: 3079311 Review. - Integrins and L-selectin in lymphocyte-endothelium interactions and homing into gut-associated tissue.
Hamann A, Jablonski-Westrich D. Hamann A, et al. Behring Inst Mitt. 1993 Aug;(92):30-5. Behring Inst Mitt. 1993. PMID: 7504455 Review.
Cited by
- RNA-binding proteins regulating the CD44 alternative splicing.
Maltseva D, Tonevitsky A. Maltseva D, et al. Front Mol Biosci. 2023 Dec 1;10:1326148. doi: 10.3389/fmolb.2023.1326148. eCollection 2023. Front Mol Biosci. 2023. PMID: 38106992 Free PMC article. Review. - New monoclonal antibodies that recognize an unglycosylated, conserved, extracellular region of CD44 in vitro and in vivo, and can block tumorigenesis.
Lusche DF, Wessels DJ, Reis RJ, Forrest CC, Thumann AR, Soll DR. Lusche DF, et al. PLoS One. 2021 Apr 23;16(4):e0250175. doi: 10.1371/journal.pone.0250175. eCollection 2021. PLoS One. 2021. PMID: 33891595 Free PMC article. - TRAF4/6 Is Needed for CD44 Cleavage and Migration via RAC1 Activation.
Kolliopoulos C, Chatzopoulos A, Skandalis SS, Heldin CH, Heldin P. Kolliopoulos C, et al. Cancers (Basel). 2021 Mar 1;13(5):1021. doi: 10.3390/cancers13051021. Cancers (Basel). 2021. PMID: 33804427 Free PMC article. - Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation.
Moorman HR, Poschel D, Klement JD, Lu C, Redd PS, Liu K. Moorman HR, et al. Cancers (Basel). 2020 Nov 15;12(11):3379. doi: 10.3390/cancers12113379. Cancers (Basel). 2020. PMID: 33203146 Free PMC article. Review. - Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma.
Park S, Jo SH, Kim JH, Kim SY, Ha JD, Hwang JY, Lee MY, Kang JS, Han TS, Park SG, Kim S, Park BC, Kim JH. Park S, et al. Cancers (Basel). 2020 Sep 7;12(9):2541. doi: 10.3390/cancers12092541. Cancers (Basel). 2020. PMID: 32906688 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous